Literature DB >> 29520625

Oro-dental pathologies in acromegaly.

Ilonka Kreitschmann-Andermahr1, Johannes Kohlmann2, Bernadette Kleist3, Ursula Hirschfelder4, Rolf Buslei5, Michael Buchfelder3, Sonja Siegel2.   

Abstract

PURPOSE: Oro-dental pathologies (ODP) such as enlargement of the tongue, mandibular prognathism, and spaced teeth are characteristic features of acromegaly. Their frequency of occurrence during the course of the disease is largely unresolved. Purpose of this study was to assess ODP and oro-dental treatments in patients with acromegaly with regard to the length of the diagnostic process, tumor histology, and quality of life (QoL).
METHODS: Single-center retrospective survey study using questionnaires on dental symptoms, diagnostic process, and treatment in patients with acromegaly operated on a growth hormone-secreting pituitary adenoma. The association between ODP and QoL was assessed using the Short-Form 36 (SF-36) Health Survey.
RESULTS: 145/314 patients completed the questionnaires. 80.7% were affected by any ODP, most frequently enlargement of the tongue (57.9%), spaced teeth (42.8%), mandibular growth (24.1%), and mandibular prognathism (22.1%). ODP were significantly more frequent in patients with sparsely vs. densely granulated adenomas (p = 0.045). Early diagnosis within 2 years was associated with significantly fewer ODP than later diagnosis (68.5 vs. 87.2%, p = 0.009). Treatments included dental crowns (16.6%), dental bridges (12.4%), dental implants (9.7%), dental prostheses (3.4%), orthodontal (i.e., braces, 6.9%), and surgical correction of the teeth (2.1%). Physical QoL was significantly lower in patients with ODP than in those without (p = 0.014).
CONCLUSION: In our large series of patients, four of five patients were affected by ODP at any time during the course of the disease. The results highlight the importance of early identification and treatment of oro-dental problems in patients with acromegaly as hallmarks of the disease.

Entities:  

Keywords:  Acromegaly; Oro-dental; Prognathism; Quality of life; Teeth

Mesh:

Year:  2018        PMID: 29520625     DOI: 10.1007/s12020-018-1571-y

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  38 in total

1.  Cephalometric assessment of cranial abnormalities in patients with acromegaly.

Authors:  Simona Dostálová; Karel Sonka; Zbynek Smahel; Vladimír Weiss; Josef Marek
Journal:  J Craniomaxillofac Surg       Date:  2003-04       Impact factor: 2.078

2.  Acromegaly identified in a patient with a complaint of malocclusion.

Authors:  T Sugata; Y Myoken; S Tanaka
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  1998-01

3.  A case of acromegaly identified after patient complaint of apertognathia.

Authors:  R B Cohen; C W Wilcox
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1993-05

4.  Impaired quality of life of patients with acromegaly: control of GH/IGF-I excess improves psychological subscale appearance.

Authors:  Maria P Matta; Elisabeth Couture; Laurent Cazals; Delphine Vezzosi; Antoine Bennet; Philippe Caron
Journal:  Eur J Endocrinol       Date:  2008-03       Impact factor: 6.664

5.  Diagnosis and management of acromegaly: the patient's perspective.

Authors:  Ilonka Kreitschmann-Andermahr; Sonja Siegel; Bernadette Kleist; Johannes Kohlmann; Daniel Starz; Rolf Buslei; Maria Koltowska-Häggström; Christian J Strasburger; Michael Buchfelder
Journal:  Pituitary       Date:  2016-06       Impact factor: 4.107

6.  Determinants of clinical outcome and survival in acromegaly.

Authors:  C Rajasoorya; I M Holdaway; P Wrightson; D J Scott; H K Ibbertson
Journal:  Clin Endocrinol (Oxf)       Date:  1994-07       Impact factor: 3.478

Review 7.  Self image and quality of life in acromegaly.

Authors:  Paola Pantanetti; Nicoletta Sonino; Giorgio Arnaldi; Marco Boscaro
Journal:  Pituitary       Date:  2002-01       Impact factor: 4.107

8.  Oral manifestations in growth hormone disorders.

Authors:  Gaurav Atreja; Shikha Handa Atreja; Nitul Jain; Urvashi Sukhija
Journal:  Indian J Endocrinol Metab       Date:  2012-05

9.  Clinical manifestations and diagnosis of acromegaly.

Authors:  Gloria Lugo; Lara Pena; Fernando Cordido
Journal:  Int J Endocrinol       Date:  2012-02-01       Impact factor: 3.257

10.  The bite force and craniofacial morphology in patients with acromegaly: a pilot study.

Authors:  Duygu Karakis; Banu Aktas-Yilmaz; Arife Dogan; Ilhan Yetkin; Bulent Bek
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2014-01-01
View more
  5 in total

1.  The tendency of reduced periodontal destruction in acromegalic patients showing similar inflammatory status with periodontitis patients.

Authors:  Yesim Ozdemir; H Gencay Keceli; Nafiye Helvaci; Tomris Erbas; Rahime M Nohutcu
Journal:  Endocrine       Date:  2019-09-02       Impact factor: 3.633

2.  The evaluation of changes in maxillofacial bones using cone beam tomography in acromegaly.

Authors:  F Dogruel; E-M Canger; Z-B Gonen; F Asantogrol; A Şahin; F Bayram
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2022-07-01

Review 3.  Oral Manifestations and Maxillo-Facial Features in the Acromegalic Patient: A Literature Review.

Authors:  Alberto De Stefani; Francesca Dassie; Alexandra Wennberg; Giorgia Preo; Alice Muneratto; Roberto Fabris; Pietro Maffei; Antonio Gracco; Giovanni Bruno
Journal:  J Clin Med       Date:  2022-02-18       Impact factor: 4.241

4.  The role of the dentist and orthodontist in recognizing oro-facial manifestations of acromegaly: a questionnaire-based study.

Authors:  Giorgia Preo; Alberto De Stefani; Francesca Dassie; Alexandra Wennberg; Roberto Vettor; Pietro Maffei; Antonio Gracco; Giovanni Bruno
Journal:  Pituitary       Date:  2021-09-13       Impact factor: 4.107

5.  Assessment of oro-dental manifestations in a series of acromegalic patients, the AcroDent study.

Authors:  Sylvain Roumeau; Joannice Thevenon; Lemlih Ouchchane; Salwan Maqdasy; Marie Batisse-Lignier; Christian Duale; Nathalie Pham Dang; Philippe Caron; Igor Tauveron; Laurent Devoize
Journal:  Endocr Connect       Date:  2020-08       Impact factor: 3.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.